Both in Biotechnology
Eikon Therapeutics vs C4 Therapeutics
Over the past year EIKN returned −64.6% and CCCC returned +97.1%; their daily moves had a correlation of 0.42.
EIKN −64.6% CCCC +97.1%Growth of $1, one year, split-adjusted
| Metric | EIKN | CCCC |
|---|---|---|
| Price | $5.31 | $3.37 |
| Market cap | $287.6M | $414.6M |
| Today | −0.75% | +2.12% |
| 1 month | −28.3% | +7.3% |
| 6 months | −45.1% | +15.4% |
| Year to date | — | +76.4% |
| 1 year | — | +34.3% |
| Revenue growth (YoY) | — | +2.8% |
| Gross margin | — | 100.0% |
| Net margin | — | −355.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 11.8× |
| Net cash | $531.2M | $253.7M |
| Dividend yield | — | — |
| Volatility (60d) | 99.4% | 65.1% |
| Short % of float | 20.5% | 43.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).